Egetis Therapeutics gets FDA approval today on its deficiency of MCT8 rare disease. Company's mkt cap is now at whopping $4 bln that too with just 1 drug approv

Egetis Therapeutics gets FDA approval today on its deficiency of MCT8 rare disease. Company's mkt cap is now at whopping $4 bln that too with just 1 drug approved and nothing else in its pipeline imo. Check its pipeline and compare it with $VNDA pipeline.